Search General Info
Search Education
Search Partnering Companies

Philip Toleikis

London, Ontario, Canada
Dr. Toleikis is President and CEO of Sernova Corp. Previously, he consulted for various pharmaceutical, medical device and combination products companies. He held multiple roles at Angiotech Pharmaceuticals, Inc. including VP, Research and Development.
Since joining Sernova, Dr. Toleikis has secured multiple financings, including equity raises and non-dilutive grants. He has been instrumental in developing Sernova’s strategic approach in the regenerative medicine therapeutics field, in developing Sernova’s worldwide patent portfolio and developing the Cell Pouch technologies through manufacturing, preclinical and clinical development to achieve clinical studies in Canada and in the United States.
Dr. Toleikis is the author of multiple issued patents and over 110 patent applications as well as multiple peer-review journal articles.
Speaking In
[On Demand]
Sernova Corp. is a clinical-stage regenerative medicine company developing the Cell Pouch System™…